Foghorn Therapeutics (FHTX) Net Income Growth (1y) (2020 - 2026)
Foghorn Therapeutics (FHTX) Net Income Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,725.60 Bn | 68,725.31 Bn | - | -0.46% |
| 2 | Nanobiotix | 1,953.19 Bn | 1,953.13 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 472.73 Bn | 467.94 Bn | 1.35 Bn | 17,802.13% |
| 5 | Vertex Pharmaceuticals | 123.52 Bn | 116.27 Bn | 2.59 Bn | 59.59% |
| 6 | Regeneron Pharmaceuticals | 69.74 Bn | 60.99 Bn | 3.31 Bn | -10.08% |
| 7 | Belite Bio | 63.09 Bn | 63.09 Bn | - | - |
| 8 | Argenx Se | 56.42 Bn | 51.24 Bn | 1.41 Bn | 63.48% |
| 9 | Revolution Medicines | 37.76 Bn | 37.76 Bn | - | - |
| 10 | Foghorn Therapeutics | 352.57 Mn | 263.66 Mn | - | -250.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -250.88% |
| Dec 31, 2025 | -22.28% |
| Sep 30, 2025 | -118.34% |
| Jun 30, 2025 | -247.22% |
| Mar 31, 2025 | 8.13% |
| Dec 31, 2024 | 19.09% |
| Sep 30, 2024 | -33.30% |
| Jun 30, 2024 | 22.07% |
| Mar 31, 2024 | 17.95% |
| Dec 31, 2023 | 16.55% |
| Sep 30, 2023 | 44.33% |
| Jun 30, 2023 | -7.96% |
| Mar 31, 2023 | -13.28% |
| Dec 31, 2022 | 21.08% |
| Sep 30, 2022 | 74.31% |
| Jun 30, 2022 | 72.63% |
| Mar 31, 2022 | -5.54% |
| Dec 31, 2021 | -57.72% |
| Sep 30, 2021 | 1.04% |
| Jun 30, 2021 | -534.14% |